Saturday, October 31, 2026

Hasbro Stock Went Up By Over 16% In The Last 5 Sessions

Hasbro Stock Went Up By Over 16% In The Last 5 Sessions

(VIANEWS) - Shares of Hasbro (NASDAQ: HAS) rose by a staggering 16.09% in 5 sessions from $51.41 at 16.09, to $59.68 at 16:09 EST on Wednesday, after two consecutive sessions in a row of losses. NASDAQ is rising 0.39% to $12,127.99, after two successive sessions in a row of losses.

Hasbro's last close was $58.55, 37.86% under its 52-week high of $94.22.

About Hasbro

Hasbro, Inc., together with its subsidiaries, operates as a play and entertainment company in the United States and internationally. The company operates through Consumer Products, Wizards of the Coast and Digital Gaming, and Entertainment segments. The Consumer Products segment engages in the sourcing, marketing, and sale of toy and game products. This segment also promotes its brands through the out-licensing of trademarks, characters, and other brand and intellectual property rights to third parties through the sale of branded consumer products, such as toys and apparels. Its toys and games include action figures, arts and crafts and creative play products, fashion and other dolls, play sets, preschool toys, plush products, sports action blasters and accessories, vehicles and toy-related specialty products, games, and other consumer products; and licensed products, such as apparels, publishing products, home goods and electronics, and toy products. The Wizards of the Coast and Digital Gaming segment engages in the promotion of its brands through the development of trading card, role-playing, and digital game experiences based on Hasbro and Wizards of the Coast games. The Entertainment segment engages in the development, acquisition, production, distribution, and sale of world-class entertainment content, including film, scripted and unscripted television, family programming, digital content, and live entertainment. The company sells its products to retailers, distributors, wholesalers, discount stores, drug stores, mail order houses, catalog stores, department stores, and other traditional retailers, as well as ecommerce retailers; and directly to customer through Hasbro PULSE e-commerce website. The company was founded in 1923 and is headquartered in Pawtucket, Rhode Island.

Earnings Per Share

As for profitability, Hasbro has a trailing twelve months EPS of $0.86.

PE Ratio

Hasbro has a trailing twelve months price to earnings ratio of 69.4. Meaning, the purchaser of the share is investing $69.4 for every dollar of annual earnings.

Yearly Top and Bottom Value

Hasbro's stock is valued at $59.68 at 16:09 EST, way below its 52-week high of $94.22 and way above its 52-week low of $45.75.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Hasbro's stock is considered to be overbought (>=80).

Volatility

Hasbro's last week, last month's, and last quarter's current intraday variation average was 3.50%, 0.56%, and 1.73%.

Hasbro's highest amplitude of average volatility was 4.07% (last week), 1.60% (last month), and 1.73% (last quarter).

Volume

Today's last reported volume for Hasbro is 1633173 which is 42.76% below its average volume of 1997880.

More news about Hasbro (HAS).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com